PSMA UPTAKE, ACCESS APPEAR HIGH FOR US-BASED UROLOGISTS.
In: Urology Times, Jg. 51 (2023-09-01), Heft 9, S. 14-17
Online
serialPeriodical
Zugriff:
The article reveals the high percentage of urologist access to prostate-specific membrane antigen (PSMA)-targeting agents and PSMA-positron emission tomography among U.S.-based practitioners, according to a survey. Among the PSMA-targeting agents used by urologists are piflufolastat, selected gallium 68 PSMA-11 and lutenium Lu 177 vipivotide tetraxetan. The survey results report the wait times for PSMA scans, prior authorization, and provider satisfaction with PSMA scan quality,
Titel: |
PSMA UPTAKE, ACCESS APPEAR HIGH FOR US-BASED UROLOGISTS.
|
---|---|
Autor/in / Beteiligte Person: | Saylor, Benjamin P. |
Link: | |
Zeitschrift: | Urology Times, Jg. 51 (2023-09-01), Heft 9, S. 14-17 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0093-9722 (print) |
Schlagwort: |
|
Sonstiges: |
|